237 related articles for article (PubMed ID: 15177682)
1. Comparative genomics: the evolutionary history of the Bcl-2 family.
Lanave C; Santamaria M; Saccone C
Gene; 2004 May; 333():71-9. PubMed ID: 15177682
[TBL] [Abstract][Full Text] [Related]
2. Identification of core structural residues in the sequentially diverse and structurally homologous Bcl-2 family of proteins.
Lama D; Sankararamakrishnan R
Biochemistry; 2010 Mar; 49(11):2574-84. PubMed ID: 20141168
[TBL] [Abstract][Full Text] [Related]
3. Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins.
Gurudutta GU; Verma YK; Singh VK; Gupta P; Raj HG; Sharma RK; Chandra R
FEBS Lett; 2005 Jul; 579(17):3503-7. PubMed ID: 15949801
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells.
Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA
Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246
[TBL] [Abstract][Full Text] [Related]
5. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region.
Coultas L; Pellegrini M; Visvader JE; Lindeman GJ; Chen L; Adams JM; Huang DC; Strasser A
Cell Death Differ; 2003 Feb; 10(2):185-92. PubMed ID: 12700646
[TBL] [Abstract][Full Text] [Related]
6. Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators.
Aouacheria A; Brunet F; Gouy M
Mol Biol Evol; 2005 Dec; 22(12):2395-416. PubMed ID: 16093567
[TBL] [Abstract][Full Text] [Related]
7. A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain.
Hossini AM; Geilen CC; Fecker LF; Daniel PT; Eberle J
Oncogene; 2006 Apr; 25(15):2160-9. PubMed ID: 16288206
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in the development and maintenance of the immune system.
Opferman JT; Korsmeyer SJ
Nat Immunol; 2003 May; 4(5):410-5. PubMed ID: 12719730
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
[TBL] [Abstract][Full Text] [Related]
10. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
Yin XM; Oltvai ZN; Korsmeyer SJ
Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family.
Scorilas A; Kyriakopoulou L; Yousef GM; Ashworth LK; Kwamie A; Diamandis EP
Genomics; 2001 Mar; 72(2):217-21. PubMed ID: 11401436
[TBL] [Abstract][Full Text] [Related]
12. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
13. Bax activation and mitochondrial insertion during apoptosis.
Lalier L; Cartron PF; Juin P; Nedelkina S; Manon S; Bechinger B; Vallette FM
Apoptosis; 2007 May; 12(5):887-96. PubMed ID: 17453158
[TBL] [Abstract][Full Text] [Related]
14. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
15. Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins.
Joseph MK; Solomon LR; Petros AM; Cai J; Simmer RL; Zhang H; Rosenberg S; Ng SC
Oncogene; 2004 Jan; 23(3):835-8. PubMed ID: 14737118
[TBL] [Abstract][Full Text] [Related]
16. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
Zhou H; Hou Q; Chai Y; Hsu YT
Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
[TBL] [Abstract][Full Text] [Related]
17. BCL-2 gene family and the regulation of programmed cell death.
Korsmeyer SJ
Cancer Res; 1999 Apr; 59(7 Suppl):1693s-1700s. PubMed ID: 10197582
[TBL] [Abstract][Full Text] [Related]
18. Molecular evolution of apoptotic pathways: cloning of key domains from sponges (Bcl-2 homology domains and death domains) and their phylogenetic relationships.
Wiens M; Krasko A; Müller CI; Müller WE
J Mol Evol; 2000 Jun; 50(6):520-31. PubMed ID: 10835482
[TBL] [Abstract][Full Text] [Related]
19. Evidence for crucial electrostatic interactions between Bcl-2 homology domains BH3 and BH4 in the anti-apoptotic Nr-13 protein.
Lalle P; Aouacheria A; Dumont-Miscopein A; Jambon M; Venet S; Bobichon H; Colas P; Deléage G; Geourjon C; Gillet G
Biochem J; 2002 Nov; 368(Pt 1):213-21. PubMed ID: 12133006
[TBL] [Abstract][Full Text] [Related]
20. How the Bcl-2 family of proteins interact to regulate apoptosis.
van Delft MF; Huang DC
Cell Res; 2006 Feb; 16(2):203-13. PubMed ID: 16474435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]